TLDR Metaplanet purchased 1,009 BTC worth $112M at $111,094 average price. The firm now holds 20,000 BTC, ranking sixth among public companies. Metaplanet targets 30,000 BTC by year-end 2025, up from 10,000 earlier. Shares fell 3.87% as investors weighed dilution risks from new funding. Metaplanet has expanded its Bitcoin holdings to 20,000 BTC after a [...] The post Japan’s Metaplanet Now Holds 20000 BTC After $112M Treasury Purchase appeared first on CoinCentral.TLDR Metaplanet purchased 1,009 BTC worth $112M at $111,094 average price. The firm now holds 20,000 BTC, ranking sixth among public companies. Metaplanet targets 30,000 BTC by year-end 2025, up from 10,000 earlier. Shares fell 3.87% as investors weighed dilution risks from new funding. Metaplanet has expanded its Bitcoin holdings to 20,000 BTC after a [...] The post Japan’s Metaplanet Now Holds 20000 BTC After $112M Treasury Purchase appeared first on CoinCentral.

Japan’s Metaplanet Now Holds 20000 BTC After $112M Treasury Purchase

TLDR

  • Metaplanet purchased 1,009 BTC worth $112M at $111,094 average price.

  • The firm now holds 20,000 BTC, ranking sixth among public companies.

  • Metaplanet targets 30,000 BTC by year-end 2025, up from 10,000 earlier.

  • Shares fell 3.87% as investors weighed dilution risks from new funding.


Metaplanet has expanded its Bitcoin holdings to 20,000 BTC after a new purchase worth $112 million. The Japanese firm is moving closer to its 2025 goal, yet questions remain about whether it can challenge the larger corporate treasuries led by Michael Saylor’s Strategy.

Metaplanet acquires 1,009 BTC for treasury

The Tokyo-based company disclosed on Monday that it acquired 1,009 BTC at an average price of about $111,094. The investment totaled 16.48 billion yen, or roughly $112 million. Based on Bitcoin’s price of $107,360 at press time, the company’s holdings are now valued at more than $2.14 billion.

This purchase raises Metaplanet’s total stash to 20,000 BTC. The company now ranks as the sixth-largest corporate Bitcoin holder worldwide. According to BitcoinTreasuries data, it is expected to surpass Riot Platforms, which held 19,239 BTC in its reserves.

Meanwhile, Metaplanet has set an ambitious goal of reaching 30,000 BTC in treasury by the end of 2025. To achieve this, the company must acquire roughly 2,500 BTC each month for the next four months.

Earlier this year, the company had targeted 10,000 BTC by year-end but exceeded the milestone months in advance. Longer term, Metaplanet aims to accumulate 210,000 BTC by 2027, equal to 1% of Bitcoin’s total supply.

Funding growth through capital markets

The company’s expansion strategy has relied heavily on raising capital from equity markets. Between July 10 and August 29, it issued more than 80 million new shares.

Most of the proceeds were directed toward redeeming bonds early and purchasing more Bitcoin.

To measure its performance, Metaplanet has introduced a metric called BTC Yield. This indicator tracks growth in Bitcoin holdings per fully diluted share. In the latest quarter-to-date, the company reported a BTC Yield of 30.7%, after achieving 129.4% in the previous quarter.

Shareholder meeting set for fresh capital raise

The latest acquisition comes as Metaplanet prepares for a shareholder meeting on its proposed international share offering. The plan involves issuing 555 million new shares to raise around 130 billion yen ($837 million). The funds would support further Bitcoin purchases over the next two months.

Eric Trump, a member of Metaplanet’s Strategic Board of Advisors, is expected to attend the meeting. However, market reaction has been cautious. On September 1, the company’s shares fell 3.87% during morning trading in Japan, as investors weighed dilution risks.

Despite the pullback, Metaplanet remains one of the most active stocks in Japan. Its shares have gained more than 136% year-to-date, supported by its Bitcoin strategy and inclusion in benchmark indexes such as the FTSE Japan Index.

The post Japan’s Metaplanet Now Holds 20000 BTC After $112M Treasury Purchase appeared first on CoinCentral.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$95,482.46
$95,482.46$95,482.46
-1.33%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26